Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 11 min 36 sec ago

Osiris Therapeutics Promotes Frank Czworka to Vice President and General Manager of Wound Care

Wed, 02/12/2014 - 16:11
COLUMBIA, Md.--(Healthcare Sales & Marketing Network)--Osiris Therapeutics, Inc. (OSIR), the leading stem cell company focused on developing and marketing products to treat conditions in wound care, orthopedic and sports medicine markets is pleased to anno...
Devices, Regenerative Medicine, Wound Care, Personnel
Osiris Therapeutics, Grafix, stem cell

DEKA Medical Receives FDA Clearance for the Synchro REPLA:Y

Wed, 02/12/2014 - 16:06
BRANFORD, Conn., Feb. 12, 2014 -- (Healthcare Sales & Marketing Network) -- DEKA Medical, Inc., a leading developer and distributor of a wide range of light-based aesthetic systems, today announced that it has recently received clearance from the FDA for ...
Devices, Dermatology, FDA
DEKA Medical, Synchro REPLA:Y, Alexandrite laser, Nd:YAG laser

Arvinas Hires Jim Winkler as Chief Scientific Officer

Tue, 02/11/2014 - 16:11
Company adds Scott Biller to its Scientific Advisory Board NEW HAVEN, Conn., Feb. 11, 2014 -- (Healthcare Sales & Marketing Network) -- Arvinas Inc., a biotechnology company creating a new class of drugs based on protein degradation, today announced th...
Biopharmaceuticals, Personnel
Arvinas, protein degradation

Zocere Appoints Zavitz as Chief Scientific Officer

Tue, 02/11/2014 - 16:09
Zavitz adds depth to leadership team as company seeks to accelerate development of promising injectable neuroprotectant drug ALBUQUERQUE, N.M.--(Healthcare Sales & Marketing Network)--New Mexico-based pharmaceutical company, Zocere, Inc., has named Kent...
Biopharmaceuticals, Neurology, Personnel
Zocere, neuroprotectant

Mallinckrodt plc to Acquire Cadence Pharmaceuticals, Inc. for $14.00 Per Share, in Cash

Tue, 02/11/2014 - 13:05
Transaction accelerates growth in Mallinckrodt’s Specialty Pharmaceuticals segment with addition of a high-growth, differentiated pain product Acquisition supports Mallinckrodt’s expansion into the hospital channel Acquisition expected to be immediat...
Biopharmaceuticals, Mergers & Acquisitions
Mallinckrodt plc, Cadence Pharmaceuticals

Lithera Announces Final Closing of $35.6 Million Series C Financing

Tue, 02/11/2014 - 13:00
SAN DIEGO, Feb. 11, 2014 -- (Healthcare Sales & Marketing Network) -- Lithera, Inc. ("Lithera" or "the Company"), a clinical stage pharmaceutical company focused on lifestyle and medical indications in aesthetic medicine and ophthalmolo...
Biopharmaceuticals, Venture Capital
Lithera, LIPO-102, LIPO-202

Tokai Pharmaceuticals Appoints John McBride as Chief Operating Officer

Tue, 02/11/2014 - 12:56
CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer and other hormonally driven cancers, today announced the appointment of John McBride...
Biopharmaceuticals, Oncology, Personnel
Tokai Pharmaceuticals, Galeterone, prostate cancer

Innovus Pharma Expands Management Team and Adds Chief Financial Officer

Tue, 02/11/2014 - 12:47
Lynnette Dillen Brings 20 Years' Experience in Finance, Accounting LA JOLLA, Calif., Feb. 11, 2014 -- (Healthcare Sales & Marketing Network) -- Innovus Pharmaceuticals, Inc., ("Innovus Pharma") (INNV), today announced tha...
Biopharmaceuticals, Personnel
Innovus Pharmaceuticals

Former Amgen Finance Executive Carl Adams Joins NeuroSigma As Vice President and Controller

Tue, 02/11/2014 - 12:43
LOS ANGELES, Feb. 11, 2014 -- (Healthcare Sales & Marketing Network) -- NeuroSigma, Inc. (NeuroSigma), a California-based life sciences company focused on commercialization of its non-invasive Monarch™ eTNS™ System for the treatment of neurological and ne...
Devices, Neurology, Personnel
NeuroSigma, Monarch, eTNS System

AliveCor Receives FDA Over-the-Counter Clearance for Its Heart Monitor

Mon, 02/10/2014 - 16:00
Provides an easier way for individuals to participate in their heart health SAN FRANCISCO--(Healthcare Sales & Marketing Network)--AliveCor, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted the company over-the-counter (...
Devices, Cardiology, Monitoring, FDA, Product Launch
AliveCor, Heart Monitor, ECG

ACell Launches New MatriStem(R) Multilayer Wound Matrix Device

Mon, 02/10/2014 - 15:52
Solution for deep, hard-to-heal wounds with additional contouring functionality COLUMBIA, Md., Feb. 10, 2014 -- (Healthcare Sales & Marketing Network) -- ACell, Inc., a leading regenerative medicine company focused on the development, manufacturing and...
Devices, Regenerative Medicine, Wound Care, Product Launch
ACell , MatriStem, Multilayer Wound Matrix

Smiths Medical Launches MR Conditional Wire-reinforced Silicone Tracheostomy Tubes for Neonates and Pediatric Patients

Mon, 02/10/2014 - 15:47
Company introduces standard version of Bivona FlexTend™ TTS™ cuffed tracheostomy tubes for children in healthcare and homecare settings ST. PAUL, Minn.--(Healthcare Sales & Marketing Network)--Smiths Medical, a leading global medical device manufacture...
Devices, Product Launch
Smiths Medical, Bivona FlexTend, tracheostomy tube

Mast Therapeutics Signs Definitive Agreement To Acquire Aires Pharmaceuticals, Inc.

Mon, 02/10/2014 - 13:35
All-stock transaction Conference call to discuss pending acquisition today at 8:30am Eastern Time SAN DIEGO, Feb. 10, 2014 -- (Healthcare Sales & Marketing Network) -- Mast Therapeutics, Inc. (NYSE MKT: MSTX) today announced that it has entered into...
Biopharmaceuticals, Mergers & Acquisitions
Mast Therapeutics, Aires Pharmaceuticals

Two-Year Results From Phase 3 VISTA Trial of EYLEA(R) (aflibercept) Injection for the Treatment of Diabetic Macular Edema Show Sustained Improvement in Vision

Mon, 02/10/2014 - 13:29
TARRYTOWN, N.Y., Feb. 10, 2014 -- (Healthcare Sales & Marketing Network) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Bayer HealthCare today announced that in the Phase 3 VISTA-DME trial of EYLEA® (aflibercept) Injection for the treatment of ...
Biopharmaceuticals, Ophthalmology
Regeneron Pharmaceuticals, Bayer HealthCare, EYLEA, aflibercept, VISTA-DME

Sunesis Appoints Joseph I. DePinto as Chief Commercial Officer, Updates VALOR Timeline to Unblinding of Data

Mon, 02/10/2014 - 13:18
SOUTH SAN FRANCISCO, Calif., Feb. 10, 2014 -- (Healthcare Sales & Marketing Network) -- Sunesis Pharmaceuticals, Inc. (SNSS) today announced the appointment of Joseph I. DePinto to the newly created position of Executive Vice President and Chief Commercial...
Biopharmaceuticals, Oncology, Personnel
Sunesis Pharmaceuticals, Vosaroxin

Alliqua Appoints Janice M. Smiell, M.D. as its First Chief Medical Officer

Mon, 02/10/2014 - 13:14
Extensive Wound Care Experience Adds Strength to Management Team LANGHORNE, Pa.--(Healthcare Sales & Marketing Network)--Alliqua, Inc. (ALQA) (“Alliqua” or “the Company”) has appointed Janice M. Smiell, M.D. as its Chief Medical Officer, a newly created...
Devices, Wound Care, Personnel
Alliqua, SilverSeal

New Breast Cancer Surgical Guidelines Can Reduce Unnecessary Procedures and Patient Costs

Mon, 02/10/2014 - 13:08
Guidelines Result from Susan G. Komen Funding of Medical Consortium that Included Leading Practitioners and Komen Patient Advocate DALLAS--(Healthcare Sales & Marketing Network)--New surgical guidelines announced today by the Society of Surgical Oncolog...
Oncology, Surgery
Susan G. Komen, breast cancer

SciClone Appoints Charles Meng as General Counsel and Vice President of Compliance

Mon, 02/10/2014 - 13:01
FOSTER CITY, CA--(Healthcare Sales & Marketing Network) - SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced the appointment of Charles Meng as General Counsel and Vice President of Compliance effective February 9, 2014. Mr. Meng has more than ...
Biopharmaceuticals, Personnel
SciClone Pharmaceuticals, ZADAXIN, thymalfasin, hepatitis B

Leading Industry Analyst Amit Bhalla Joins BD as Vice President, Global Strategy and Development

Fri, 02/07/2014 - 16:01
FRANKLIN LAKES, N.J., Feb. 7, 2014 -- (Healthcare Sales & Marketing Network) -- BD (Becton, Dickinson and Company) (BDX), a leading global technology company, today announced the appointment of Amit Bhalla as Vice President, Global Strategy and Developmen...
Devices, Personnel
BD , Amit Bhalla

Covis Pharmaceuticals Announces Its New Expanded Dosage Options of LANOXIN(R) for Cardiac Patients With Mild-to-Moderate Heart Failure

Fri, 02/07/2014 - 15:57
CARY, N.C., Feb. 7, 2014 -- (Healthcare Sales & Marketing Network) -- Covis Pharmaceuticals today announced that LANOXIN® is now offered in four dosage strengths, including the new 0.0625mg and 0.1875mg strengths, for the treatment of mild-to-moderate...
Biopharmaceuticals, Cardiology
Covis Pharmaceuticals, LANOXIN, Digoxin, heart failure

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong